0001656472-21-000035.txt : 20210318
0001656472-21-000035.hdr.sgml : 20210318
20210318174934
ACCESSION NUMBER: 0001656472-21-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210316
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN
CENTRAL INDEX KEY: 0001797199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38403
FILM NUMBER: 21755624
MAIL ADDRESS:
STREET 1: 111 PETER STREET, SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cronos Group Inc.
CENTRAL INDEX KEY: 0001656472
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCan Capital Corp.
DATE OF NAME CHANGE: 20151021
4
1
wf-form4_161610415705055.xml
FORM 4
X0306
4
2021-03-16
0
0001656472
Cronos Group Inc.
CRON
0001797199
GORENSTEIN MICHAEL RYAN
111 PETER STREET, SUITE 300
TORONTO
A6
M5V 2H1
ONTARIO, CANADA
1
1
0
0
Executive Chairman
COMMON SHARES
2021-03-16
4
M
0
437500
1.9391
A
8870036
D
COMMON SHARES
2021-03-16
4
F
0
175178
10.6974
D
8694858
D
COMMON SHARES
2021-03-16
4
M
0
1272916
2.5161
A
9967774
D
COMMON SHARES
2021-03-16
4
F
0
559960
10.6974
D
9407814
D
COMMON SHARES
2021-03-16
4
M
0
103125
6.0658
A
9510939
D
COMMON SHARES
2021-03-16
4
F
0
70427
10.6974
D
9440512
D
COMMON SHARE OPTION (right to buy)
1.9391
2021-03-16
4
M
0
437500
0
D
2022-08-24
COMMON SHARES
437500.0
62500
D
COMMON SHARE OPTION (right to buy)
2.5161
2021-03-16
4
M
0
1272916
0
D
2022-04-12
COMMON SHARES
1272916.0
27084
D
COMMON SHARE OPTION (right to buy)
6.0658
2021-03-16
4
M
0
103125
0
D
2023-05-17
COMMON SHARES
103125.0
46875
D
The price reported was converted from the Canadian exercise price of C$2.42 to U.S. dollars using an exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021.
Cronos Group Inc. (the "Company") withheld 175,178 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 15, 2021 of C$13.35 as reported on the Toronto Stock Exchange.
The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021.
The price reported was converted from the Canadian exercise price of C$3.14 to U.S. dollars using an exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021.
The Company withheld 559,960 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 15, 2021 of C$13.35 as reported on the Toronto Stock Exchange.
The price reported was converted from the Canadian exercise price of C$7.57 to U.S. dollars using an exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021.
The Company withheld 70,427 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 15, 2021 of C$13.35 as reported on the Toronto Stock Exchange.
The options were granted August 24, 2017 and vest in monthly installments over a four-year period.
The options were granted April 12, 2017 and vest in monthly installments over a four-year period.
The options were granted May 17, 2018 and vest in monthly installments over a four-year period.
/s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein
2021-03-18